Abstract:Accurate diagnosis of the initial phase of Alzheimer's disease (AD) is essential and crucial. The objective of this research was to employ efficient biomarkers for the diagnostic analysis and classification of AD based on combining structural MRI (sMRI) and resting-state functional MRI (rs-fMRI). So far, several anatomical MRI imaging markers for AD diagnosis have been identified. The use of cortical and subcortical volumes, the hippocampus, and amygdala volume, as well as genetic patterns, has proven to be beneficial in distinguishing patients with AD from the healthy population. The fMRI time series data have the potential for specific numerical information as well as dynamic temporal information. Voxel and graphical analyses have gained popularity for analyzing neurodegenerative diseases, such as Alzheimer's and its prodromal phase, mild cognitive impairment (MCI). So far, these approaches have been utilized separately for the diagnosis of AD. In recent studies, the classification of cases of MCI into those that are not converted for a certain period as stable MCI (MCIs) and those that converted to AD as MCIc has been less commonly reported with inconsistent results. In this study, we verified and validated the potency of a proposed diagnostic framework to identify AD and differentiate MCIs from MCIc by utilizing the efficient biomarkers obtained from sMRI, along with functional brain networks of the frequency range .01-.027 at the resting state and the voxel-based features. The latter mainly included default mode networks (amplitude of low-frequency fluctuation [ALFF], fractional ALFF [ALFF], and regional homogeneity [ReHo]), degree centrality (DC), and salience networks (SN). Pearson's correlation coefficient for measuring fMRI functional networks has proven to be an efficient means for disease diagnosis. We applied the graph theory to calculate nodal features (nodal degree [ND], nodal path length [NL], and between centrality [BC]) as a graphical feature and analyzed the connectivity link between different brain regions. We extracted three-dimensional (3D) patterns to calculate regional coherence and then implement a univariate statistical t-test to access a 3D mask that preserves voxels showing significant changes. Similarly, from sMRI, we calculated the hippocampal subfield and amygdala nuclei volume using Freesurfer (version 6). Finally, we implemented and compared the different feature selection algorithms to integrate the structural features, brain networks, and voxel features to optimize the diagnostic identifications of AD using support vector machine (SVM) classifiers. We also compared the performance of SVM with Random Forest (RF) classifiers. The obtained results demonstrated the potency of our framework, wherein a combination of the hippocampal subfield, the amygdala volume, and brain networks with multiple measures of rs-fMRI could significantly enhance the accuracy of other approaches in diagnosing AD. The accuracy obtained by the proposed method was reported for binary classification. More importantly, the classification results of the less commonly reported MCIs vs. MCIc improved significantly. However, this research involved only the AD Neuroimaging Initiative (ADNI) cohort to focus on the diagnosis of AD advancement by integrating sMRI and fMRI. Hence, the study's primary disadvantage is its small sample size. In this case, the dataset we utilized did not fully reflect the whole population. As a result, we cannot guarantee that our findings will be applicable to other populations.

Unraveling Alzheimer's Disease: Investigating Dynamic Functional Connectivity in the Default Mode Network through DCC-GARCH Modeling

Multigroup Recognition of Dementia Patients with Dynamic Brain Connectivity under Multimodal Cortex Parcellation

A deep spatio-temporal attention model of dynamic functional network connectivity shows sensitivity to Alzheimer's in asymptomatic individuals

Exploring Dynamic Functional Connectivity Alterations in the Preclinical Stage of Alzheimer's Disease: an Exploratory Study from SILCODE

Abnormal Dynamic Functional Connectivity in Alzheimer’s Disease

Abnormal dynamic functional connectivity and brain states in Alzheimer's diseases: functional near-infrared spectroscopy study.

Exploring dynamic functional connectivity alterations in the preclinical stage of Alzheimer’s disease: an exploratory study from SILCODE

Prediction of Cognitive Progression Due to Alzheimer's Disease in Normal Subjects Based on Individual Default Mode Network Metabolic Connectivity Strength

Dynamic Functional Connectivity and Graph Convolution Network for Alzheimer's Disease Classification

Abnormal Characterization of Dynamic Functional Connectivity in Alzheimer's Disease

Investigation of the Effective Connectivity of Resting State Networks in Alzheimer'S Disease: A Functional Mri Study Combining Independent Components Analysis and Multivariate Granger Causality Analysis

ABNORMAL BRAIN CONNECTIVITY DYNAMICS AND BRAIN ACTIVITY STATES IN ALZHEIMER’S DISEASE

Identification of Alzheimer's Disease Progression Stages Using Topological Measures of Resting-State Functional Connectivity Networks: A Comparative Study

Evaluating functional connectivity of executive control network and frontoparietal network in Alzheimer’s disease

TRACKING REGIONAL CONNECTIVITY DYNAMICS IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE

Detection of Alzheimer’s Disease Using Dynamic Functional Connectivity Patterns in Resting-State fMRI

Abnormal Dynamic Functional Networks in Subjective Cognitive Decline and Alzheimer's Disease

Prediction of Alzheimer's Disease Using Individual Structural Connectivity Networks

Altered Effective Connectivity Patterns of the Default Mode Network in Alzheimer's Disease: an Fmri Study

Spectral Dynamic Causal Modelling of Resting-State fMRI: Relating Effective Brain Connectivity in the Default Mode Network to Genetics

Alzheimer's Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural MRI